0000792977-19-000128.txt : 20191010
0000792977-19-000128.hdr.sgml : 20191010
20191010170435
ACCESSION NUMBER: 0000792977-19-000128
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191008
FILED AS OF DATE: 20191010
DATE AS OF CHANGE: 20191010
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FONTEYNE PAUL R.
CENTRAL INDEX KEY: 0001727550
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10865
FILM NUMBER: 191146605
MAIL ADDRESS:
STREET 1: C/O RESTORBIO, INC.
STREET 2: 501 BOYLSTON STREET SUITE 6102
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000792977
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 042742593
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1100 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 6174983300
MAIL ADDRESS:
STREET 1: 1100 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: AMAG PHARMACEUTICALS INC.
DATE OF NAME CHANGE: 20070724
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MAGNETICS INC
DATE OF NAME CHANGE: 19920703
4
1
wf-form4_157074145269453.xml
FORM 4
X0306
4
2019-10-08
0
0000792977
AMAG PHARMACEUTICALS, INC.
AMAG
0001727550
FONTEYNE PAUL R.
C/O AMAG PHARMACEUTICALS, INC.
1100 WINTER STREET
WALTHAM
MA
02451
1
0
0
0
Common Stock
2019-10-08
4
A
0
4407
A
4407
D
Stock Option (Right to Buy)
11.58
2019-10-08
4
A
0
6000
A
2029-10-08
Common Stock
6000.0
6000
D
Stock Option (Right to Buy)
11.58
2019-10-08
4
A
0
9452
A
2029-10-08
Common Stock
9452.0
9452
D
Each restricted stock unit represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the "Issuer"). These shares of Common Stock are issuable pursuant to a grant of restricted stock units pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan") that will vest in seven equal monthly installments beginning on November 1, 2019; however, delivery of the shares is deferred until the earlier of (a) one year from the date of grant and (b) the date of the director's separation from service to the Issuer.
Not applicable.
Grant of stock option pursuant to the Plan. This option will vest and become exercisable in twenty-four equal monthly installments over two years from the date of grant.
Grant of stock option pursuant to the Plan. This option will vest and become exercisable in seven equal monthly installments commencing November 1, 2019.
Nancy R. Smith, attorney-in-fact
2019-10-10